In this report, Chao et al. explored the dynamics of platelet activation in patients with COVID-19, across a four-week period encompassing acute illness and convalescence. Most patients (75.4%) received two transfusions;15.1% patients received one;and 9.5% received three. I High-titer convalescent plasma did not reduce death or progression to severe respiratory failure in patients hospitalized with COVID-19 in the i " I Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 [TSUNAMI] i " I trial i . [Extracted from the article] Copyright of Transfusion is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
A monthly roundup of key articles in other journals